Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecan

Janelle M. Hoskins, Gary L. Rosner, Mark J. Ratain, Howard L. McLeod, Federico Innocenti

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecan'. Together they form a unique fingerprint.

Medicine & Life Sciences